Doctors worry about FDA scrutiny of RSV shots to protect babies

An electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus virions, colorized blue, and antibodies against an RSV protein, colorized yellow.

The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The drugmakers behind them maintain they're safe.

(Image credit: AP)